In focus
Latest feed
A Legal Rollercoaster: Corcept's Stock Takes a Dive as Appeals Court Backs Teva in Key Patent Spat
Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug
Lupin Unleashes Affordable Overactive Bladder Treatment in the U.S. Market
FDA Greenlights Second Generic Abortion Pill, Igniting Fierce Conservative Opposition
